|
Indication Being Studied: Heartburn / Acid Reflux / GERD
Summary of Study: This study is open to men and women age 18 to 65 who have been experiencing heartburn symptoms at least three days week and are on a stable low dose of an approved PPI (proton pump inhibitor), which include:
| Aciphex |
20 mg |
| Nexium |
20mg |
| Prevacid |
15mg |
| Protonix |
20mg |
| Prilosec (omeprazole) |
20mg |
| Zegerid |
20mg |
| Kapidex |
30mg |
If you are currently taking one of the above mentioned medications at the listed dose, you may be a good candidate for this study.
Individuals who qualify to participate in this study will receive their current PPI for the duration of participation in the study along with study medication and study-related medical care at no cost to the participant or their insurance.
Number of Visits: Up to 10 visits.
Duration of Study: Up to 11 weeks.
Who Can Participate: Apart from the criteria mentioned above, additional inclusion/exclusion criteria will be reviewed with interested individuals during screening.
Subject Compensation: Subject conpensation (up to $750) may be available for time and travel for participating in the study.
For More Information: If you or someone you know is interested in participating in this trial, or if you simply want more information, contact us today at (801) 409-2040. |
